Application
ESI-09 has been used as an antagonist for exchange factor directly activated by cAMP (EPAC).
Biochem/physiol Actions
ESI-09 is a potent, specific inhibitor of EPAC (exchange protein directly activated by cAMP). ESI-09 inhibits EPAC1 and EPAC2 with IC50 values of 3.2 and 1.4 µM, respectively, with no activity against PKA at 25 µM. In pancreatic cell lines, the compound blocks phosphorylation of Akt and insulin secretion. ESI-09 inhibits migration of pancreatic cancer cell lines.
Packaging
5, 25 mg in glass bottle
This product has met the following criteria to qualify for the following awards: